Peters on Diabetes

 
 

  • Diabetes Drugs: The Latest Good -- and Bad -- News   Dr Anne Peters discusses hot topics in type 2 diabetes treatment: liraglutide shows CV benefits, whereas some SGLT2 inhibitors show renal protection -- and potential harm.
  • New Metformin Rule 'Makes Me Incredibly Happy'   New prescribing guidelines for metformin will make clinicians' lives easier, and they are good for patients, too, says Dr Anne Peters.
  • Wait for It: Diabetes News Eagerly Anticipated   Dr Anne Peters reveals which stories she will be following during the upcoming meeting of the American Diabetes Association in New Orleans.
  • Lower CV Risk -- With a Diabetes Drug   Dr Peters shares a recent case where she prescribed diabetes drugs for the purpose of helping a patient reduce his cardiovascular disease risk.
  • What I Want for Christmas (Next Year)   Dr Anne Peters shares her holiday "wish list" for improvements in diabetes care in the coming year.
  • New Insulins: Benefits and Challenges   Dr Anne Peters explains why new insulin products have clinical benefits and how their higher costs can be managed, especially at the end of the year.
  • How EMPA-REG Has Changed My Practice   The EMPA-REG Outcomes trial found that the diabetes drug empagliflozin was not only safe but it actually provided cardiovascular benefits in high-risk patients.
  • Minimizing DKA Risk With SGLT2 Inhibitors in Type 1 Diabetes   Could dose titration and ketone monitoring make drugs designed for type 2 diabetes safe in type 1 diabetes?
  • Type 2 Diabetes Management: Choosing the Best Therapies   Two experts offer tips for sifting through the many drug options to help patients optimize management of their type 2 diabetes.
  • Demystifying the Glycemic Index: Implications for Practice   What characteristics give a food its glycemic index? What are the benefits of a low-glycemic diet? A nutritionist explains why a low-glycemic-index diet is a shortcut to health.
  • How to Counsel Type 1 Diabetes Patients Who Exercise?   Anne Peters and Bruce Bode discuss the optimal exercise prescription for athletes and patients with type 1 diabetes who want to exercise.
  • 'Understand This Warning': SGLT2s and Ketoacidosis   Dr Anne Peters describes case examples of euglycemic ketoacidosis linked to SGLT2 inhibitors used to treat type 2 diabetes.
  • CV Safety of Diabetes Drugs on ADA 2015 Program   Dr Anne Peters provides background on the cardiovascular risks of four oral diabetes drugs, which will be discussed at the upcoming annual meeting of the American Diabetes Association.
  • Inhaled Insulin: How to Teach Patients   Dr Anne Peters demonstrates the use of the new inhaled insulin device and reminds clinicians what to discuss with patients when initiating this new agent.
  • Tailoring Type 2 Diabetes Treatment: Updated Guidance   Updates to the ADA/EASD guidance on treating hyperglycemia in type 2 diabetes include a discussion of SGLT-2 inhibitors.
  • What's New in the ADA's Latest Diabetes Guidelines?   Dr Anne Peters discusses the changes to the standards of care updated annually by the American Diabetes Association.
  • Anne Peters: Advances in Diabetes, 2014 What were the most important developments in diabetes care this past year?
  • How Promising Is Brown Fat for Weight Loss?   Dr Anne Peters talks with Dr Mattias Blüher about the latest research on brown adipose tissue and the clinical applications under study.
  • 'Constant Feast' Drives Up Diabetes Rates in Saudi Arabia   Dr Anne Peters talks with Dr Aus Alzaid about the high rate of diabetes in Saudi Arabia, and the unique cultural considerations in managing and preventing diabetes in the Middle East.
  • EASD at 50: What's Driving the Future?   Sir George Alberti and Dr. Ele Ferrannini, former presidents of the European Association for the Study of Diabetes, talk with Dr. Anne Peters about how diabetes has evolved over the past 50 years.
  • Helping Diabetes Patients on 'Worst Day of My Life'   Dr. Anne Peters talks with Tami Ross, a leader in diabetes education, about how the healthcare team can help diabetes patients face their new diagnosis and go on to lead healthy, happy lives.
  • What Is an Artificial Pancreas, Really?   Whether you call it 'bionic' or 'artificial,' it's destined to revolutionize diabetes care but still fall short of some patients' expectations. Howard Zisser talks with Anne Peters at ADA 2014.
  • Fascinating Discoveries in Type 2 Diabetes   Dr. Anne Peters talks to Dr. Guy Rutter, who has made some amazing discoveries about beta-cell function in type 2 diabetes.
  • Once-Weekly Dulaglutide Effective for T2DM   Dr. Anne Peters and Dr. Kathleen Dungan discuss results of an open-label trial comparing weekly dulaglutide with daily liraglutide in type 2 diabetes.
  • Congratulations! We're Making Strides in Diabetes Care   Dr. Anne Peters reviews 3 studies that describe the state of diabetes care in the United States, with some encouraging results.
  • Getting to 'A-ha!' With Obese Patients   Dr. Anne Peters shares a patient's story of how she battled obesity and won.
  • Key Points in the ADA's New Diabetes Guidelines   Dr. Anne Peters discusses what's new and what remains important in the American Diabetes Association's 2014 revision of its Standards of Care for diabetes.
  • Anne Peters: The Year in Diabetes Although some of the year's advances represented only small steps for diabetes, they are steps toward improved care and quality of life for millions of patients.
  • How Do New Statin Guidelines Affect Diabetes Care? Although the new guidelines make LDL targets unnecessary, Dr. Anne Peters believes they still may have a place in treating patients with diabetes.
  • Gliptin Safety a 'Good Thing'   'It would have been nice' if the diabetes drugs had actually lowered cardiovascular risk, says Dr. Anne Peters.
  • Top Picks From ADA Dr. Anne Peters reports on the latest developments in the clinical management of diabetes, from the artificial pancreas to insulin, drugs, and combination agents.
  • Type 2 Diabetes in the Hospital: Glucose Management Dr. Kathleen Dungan talks with Dr. Anne Peters about key issues in managing type 2 diabetes patients who are hospitalized and then transitioned back to outpatient care.
  • Transplant Options for Patients With Type 1 Diabetes   Outcomes in whole-pancreas transplants continue to improve, as investigators study less invasive islet transplants. Dr. Michael Rickels discusses the latest developments with Dr. Anne Peters.
  • Beta Cells: 'Where It All Begins' How does dietary fat affect beta cell function in diabetes patients? Dr. Raghu Mirmira talks to Dr. Anne Peters about the research presented at the annual meeting of the American Diabetes Association.
  • AACE Algorithm Offers New Guidance on Managing T2DM   Dr. Anne Peters reviews the latest algorithm from the American Association of Clinical Endocrinologists for treating type 2 diabetes.
  • Canagliflozin: Who May Benefit From New Diabetes Drug?   Dr. Anne Peters discusses the clinical considerations in prescribing this first-in-class drug for type 2 diabetes.
  • An Unusual Case of Type 1 Diabetes -- or Is It Type 2?   Dr. Anne Peters describes her management of a lean Asian man who came to her with a diagnosis of type 1 diabetes.
  • Kazano! New Alogliptin Combos for Type 2 Diabetes   Dr. Anne Peters explains prescribing considerations for the newly approved alogliptin and its combination formulations.
  • What's New in ADA's Latest Diabetes Guidelines?   Dr. Anne Peters discusses the changes to the standards of care updated annually by the American Diabetes Association.
  • CGM: Practical Uses in Diabetes   Dr. Anne Peters discusses the real-life use of continuous glucose monitoring and recent advances in the technology.
  • Insulin for Prediabetes?   Dr. Anne Peters describes her personalized approach to treating a patient with prediabetes, using clinical trial data and the patient's input to come up with an unusual plan.
  • 'Why We Halted Look AHEAD'   Dr. Anne Peters, an investigator for Look AHEAD (Action for Health in Diabetes), explains the reasons for stopping this large national trial and provides perspective for clinicians to share with their patients.
  • How to Use New Type 2 Diabetes Guidelines   Dr. Anne Peters, an author of the ADA/EASD guidance issued earlier this year, offers a step-by-step guide to selecting the right medications for patients with type 2 diabetes.
  • Lean Adults With New Diabetes: Treatment Pearls   Dr. Anne Peters outlines key issues in the assessment and management of normal-weight patients who develop diabetes in adulthood.
  • ORIGIN Reassures Us of Insulin's Safety, Effectiveness   The results of the ORIGIN trial may not change clinical practice dramatically, says Dr. Anne Peters, but they reinforce the benefits of insulin without raising the risk for cardiovascular disease.
  • New Guidelines Clarify Treatment for Type 2 Diabetes   Clinicians can use the new guidelines to better navigate the many treatment options and deliver optimal, patient-centered care, says Dr. Anne Peters.
  • Bariatric Surgery a 'Magic Bullet' for Diabetes?   New research shows that bariatric surgery may produce better responses than standard medical therapy in obese patients with type 2 diabetes, but surgery is no panacea, warns Dr. Anne Peters.
  • Traveling With Diabetes: Help Your Patients Prepare   Patients who take insulin for diabetes may be nervous about traveling, but you can help them feel secure with these preparations explained by Dr. Anne Peters.
  • Bydureon: An Easy, Effective New Treatment for Type 2 Diabetes   How will the new once-weekly exenatide formulation fit into the overall diabetes armamentarium? Dr. Anne Peters offers a short overview.
  • I Was Shocked by What You Don’t Have   Dr. Anne Peters discusses diabetes care in Ethiopia with Dr. Ahmed Reja, President of the Ethiopian Diabetes Association, while attending the World Diabetes Congress in Dubai, UAE.
  • Diabetes Care in Poland: 'Just 1 Brick in Global System'   Dr. Leszek Czupryniak, President of Diabetes Poland, talks with Dr. Anne Peters about how diabetes care in Poland compares with that in other regions of the world.
  • What Does the Global Diabetes Epidemic Mean for US Clinicians?   The recent World Diabetes Congress offered important insights on diabetes from around the world, Dr. Anne Peters reports.
  • Managing Diabetes in Young Adults: New Guidelines   Pediatric patients with diabetes who are transitioning to adult care are particularly vulnerable, says Dr. Anne Peters, who co-chaired a committee that produced new clinical guidelines for these "emerging adults."
  • Alzheimer Risk in Diabetes: What to Tell Patients?   Patients with diabetes have been asking questions about 2 new studies related to risk for Alzheimer disease and possible treatment, reports Dr. Anne Peters.
  • Liraglutide's REMS: What's New?   A recent FDA drug advisory highlighted the potential risks of liraglutide (Victoza®) in the treatment of type 2 diabetes, but was there anything new in the data or guidance? Dr. Anne Peters discusses the issue.
  • How Does Linagliptin Compare With Other DPP-4 Inhibitors?   Linagliptin is the latest addition to the array of medications available to treat type 2 diabetes. Dr. Anne Peters describes its role in the overall armamentarium.
  • ADA Highlights: New Drugs for Diabetes   Dr. Anne Peters and Dr. Julio Rosenstock discuss the diabetes drugs that will be most important to practicing clinicians in the next few years.
  • Safety of Diabetes Drugs -- Should We Worry?   Dr. Anne Peters and Dr. John Buse discuss the risks and benefits of diabetes drugs that are getting headlines for safety reasons.
  • Building a Social Network for Type 1 Diabetes   Dr. Anne Peters speaks with Marie Schiller about innovative programs of the Helmsley Trust, which include an online network for patients with type 1 diabetes.
  • Real Life With Diabetes: What Clinicians Need to Hear   Website founder and type 1 diabetes patient Amy Tenderich describes the day-to-day battle of diabetes management from the patient's perspective.
  • Improving Continuous Glucose Monitoring Technology   Dr. Anne Peters speaks with Dr. Howard Wolpert about the benefits and limitations of continuous glucose monitoring and the "mechanical pancreas."
  • Can an IndyCar Driver With Type 1 Diabetes Still Race?   Dr. Anne Peters explains how she works with Charlie Kimball, the first licensed IndyCar driver with diabetes, whose car is outfitted with steering wheel monitors and a helmet juice pack.
  • ADA's Practice Guidelines for 2011   Dr. Anne Peters discusses the new ADA guidelines.
  • New Guideline Sets Higher Hospital Glycemia Targets   Dr. Anne Peters summarizes the latest guidance on glycemia control for hospitalized patients.
  • Diabetes in 2010: A1c, ACCORD, Avandia, Victoza, and More   Dr. Anne Peters looks back over the major milestones reached in 2010 for the diagnosis and management of diabetes.
  • TZDs for Diabetes: Tips for Safe Use   Dr. Anne Peters describes how she uses TZDs, especially pioglitazone, to maximize patients' management of diabetes while still heeding safety warnings.
  • 1 Patient, 3 Assessments: Which Is Best?   Diabetes management can take many different forms, as Dr. Anne Peters discusses in this video commentary
  • Common Supplements for Diabetes: Any Benefits?   Many patients with diabetes take supplements, such as cinnamon and fish oil. Dr. Anne Peters offers tips on how to advise patients about such therapies.
  • Emergency Kits for Patients With Diabetes: What's Needed?   Clinicians should advise patients with diabetes to prepare an emergency medical kit in case of disaster. Dr. Anne Peters shares her tips on what to pack.
  • Should We Continue Insulin Secretagogues When Starting Insulin for Type 2 Diabetes?   Dr. Anne Peters discusses new research that sheds light on this often perplexing question.
  • Transitioning Pediatric Patients With Diabetes to Adult Care   A gradual transition empowers patients to take charge of their diabetes management, explains Dr. Paola Sequeira in this discussion with Dr. Anne Peters.
  • What Key Lessons Emerged From ADA 2010?   Dr. David Kendall of the American Diabetes Association reviews highlights of the group's recent annual meeting with Dr. Anne Peters.
  • Avoiding Hypoglycemia: CGM Devices May Be the Answer   Dr. Howard Wolpert, an expert on continuous glucose monitors, discusses the importance of this technology with Dr. Anne Peters at the recent ADA annual meeting.
  • TZDs: Managing Fracture Risk -- In Men, Too   Dr. Anne Peters discusses ways to address the fracture risk associated with thiazolidinediones that are used to treat diabetes.
  • How Can We Help Our Overweight Patients?   Dr. Anne Peters discusses how to treat overweight and obese patients.
  • What Did ACCORD Teach Us About Hypertension Targets?   In this video editorial, Dr. Anne Peters reviews the "obvious" and more subtle lessons from ACCORD in regard to aggressive drug therapy to lower blood pressure and reduce cardiovascular risk in patients with type 2 diabetes mellitus
  • ACCORD Lipid Study Deserves Careful Review   Dr. Anne Peters looks beyond the hyped headlines to provide a reasoned analysis of ACCORD's findings on fenofibrate therapy in this video commentary.
  • Liraglutide: A New Treatment Option for Type 2 Diabetes Mellitus   Dr. Anne Peters reviews the benefits and risks of liraglutide in this short video commentary.
  • ADA Offers 3 New Diabetes Treatment Recommendations   Dr. Anne Peters discusses new guidelines for treating gestational diabetes, using aspirin to lower cardiovascular risk, and treating hospitalized patients with diabetes.
  • New ADA Diagnosis Guidelines: Putting Them Into Practice   Dr. Anne Peters discusses how the new focus on hemoglobin A1c values may affect your patients and your clinical practice.
  • Onset of Type 1 Diabetes: A Patient's Journey   Dr. Anne Peters recounts the story of a late-night phone call that led to the diagnosis and management of diabetes in a 14-year-old boy, stressing the importance of individualized care.
  • Treating Severe Hypoglycemia: Family and Friends Are Key   If a patient with diabetes is seizing or unconscious due to severe hypoglycemia, will family and friends know what to do? Dr. Anne Peters provides tips in this video editorial.
  • Treating Mild Hypoglycemia: The Rule of 15   Do your patients know what 15 g of glucose look like? Dr. Anne Peters offers educational tips in this video commentary.
  • Insulin Pens: A Closer Look   You may be familiar with insulin pens, but do you know exactly how they work? Dr. Anne Peters provides a quick overview in this video editorial.
  • Starting a Patient on Insulin: Needles and Pens   Dr. Anne Peters provides a step-by-step video tutorial on teaching a patient how to administer insulin, with either a vial and syringe or with a convenient pen dispenser.
  • The Diabetic Foot Exam   What are the key aspects of the all-important foot exam in patients with diabetes? Dr. Anne Peters describes and demonstrates proper techniques in this 6-minute video blog.
  • What Should We Tell Patients About Insulin Glargine?   Some patients with diabetes are panicking about reports that insulin glargine (Lantus®) may be associated with an increased risk for cancer. In this video blog, Dr. Anne Peters discusses how clinicians can best address those concerns.
  • On the RECORD: Rosiglitazone Safer Than Previously Thought   : In this video blog, Dr. Anne Peters discusses findings of the RECORD trial, which compared the cardiovascular risks for rosiglitazone with a combination of metformin and sulfonylureas.
  • Using Hemoglobin A1c Values to Diagnose Diabetes   Why did it take so long for experts to recommend this diagnostic process? Dr. Anne Peters reviews the issues in her latest video blog.
  • Tips for Initiating Insulin Therapy for Type 2 Diabetes How can you help patients reach their target glucose levels? Dr. Anne Peters provides an algorithm and other simple steps in this video blog.
  • Should We Raise Glucose Targets in the ICU? A recent study found that tighter glucose control of critically ill patients actually resulted in higher mortality. Dr. Anne Peters discusses the implications in this video blog.
  • Treating Diabetes During the Economic Crunch In this video blog, Dr. Anne Peters offers tips on helping patients maintain diabetes control without bankrupting their pocketbooks.
  • Updated ADA Guidelines for Treating Type 2 Diabetes In her latest video blog, Dr. Peters discusses the new ADA recommendations for treating type 2 diabetes.
  • World Diabetes Day 2008 In her latest video blog, Anne Peters, MD, discusses the primary global awareness campaign for the over 250 million patients with diabetes worldwide.
  • The Results of the Long-Awaited UK Prospective Diabetes Study (UKPDS) In her latest video blog, Dr. Peters discusses the long-term follow-up results from the UK Prospective Diabetes Study.
  • The Benefits of Continuous Glucose Monitoring In her latest videoblog, Dr. Peters discusses the results of a study on continuous glucose monitoring represented at the recent European Association for the Study of Diabetes meeting.
  • Diabetes Prevention and Ralph DeFronzo What did Dr. Anne Peters learn from Dr. Ralph DeFronzo? Find out in this videoblog.
  • Understanding the ACCORD, ADVANCE, and VA Trials The data may seem confusing, but in this video blog Dr. Anne Peters explains how these trials can help us better manage our diabetes patients.
  • Metformin Guidelines Does Dr. Anne Peters follow the rules on metformin use? She discusses this issue in her latest video blog.
  • Insulin Pump Safety Dr. Anne Peters is a big fan of insulin pumps, but they are not for everybody, as she discusses in this videoblog.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.